{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T15:40:01Z","timestamp":1744558801540,"version":"3.40.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,13]]},"DOI":"10.7759\/cureus.82175","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T15:07:11Z","timestamp":1744556831000},"source":"Crossref","is-referenced-by-count":0,"title":["Dynamics of SARS-CoV-2 Immunoglobulin G Antibody Among Hospitalized Patients and Healthcare Workers During the Delta Wave in Bangladesh"],"prefix":"10.7759","author":[{"given":"Md. Abdul","family":"Matin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chowdhury Adnan","family":"Sami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Ashraful Hassan","family":"Anjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan M","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraful","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Nazmul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohael Mahmud","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil  K","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazle  R","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long QX","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, et al.. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020, 26:845-8. 10.1038\/s41591-020-0897-1","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao J","year":"2020","unstructured":"Zhao J, Yuan Q, Wang H, et al.. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020, 71:2027-34. 10.1093\/cid\/ciaa344","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.09.044","article-title":"Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign","volume":"27","author":"Pan Y","year":"2021","unstructured":"Pan Y, Li X, Yang G, et al.. Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign. Clin Microbiol Infect. 2021, 27:253-7. 10.1016\/j.cmi.2020.09.044","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.051","article-title":"Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients","volume":"81","author":"Pan Y","year":"2020","unstructured":"Pan Y, Li X, Yang G, et al.. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020, 81:e28-32. 10.1016\/j.jinf.2020.03.051","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1773324","article-title":"Patterns of IgG and IgM antibody response in COVID-19 patients","volume":"9","author":"Liu X","year":"2020","unstructured":"Liu X, Wang J, Xu X, Liao G, Chen Y, Hu CH. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020, 9:1269-74. 10.1080\/22221751.2020.1773324","journal-title":"Emerg Microbes Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa489","article-title":"Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Qu J","year":"2020","unstructured":"Qu J, Wu C, Li X, et al.. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020, 71:2255-8. 10.1093\/cid\/ciaa489","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.05.008","article-title":"SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects","volume":"27","author":"Achiron A","year":"2021","unstructured":"Achiron A, Gurevich M, Falb R, Dreyer-Alster S, Sonis P, Mandel M. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Clin Microbiol Infect. 2021, 27:1349.e1-6. 10.1016\/j.cmi.2021.05.008","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.080","article-title":"Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection","volume":"107","author":"Gerhards C","year":"2021","unstructured":"Gerhards C, Thiaucourt M, Kittel M, et al.. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Int J Infect Dis. 2021, 107:221-7. 10.1016\/j.ijid.2021.04.080","journal-title":"Int J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060587","article-title":"Titers, prevalence, and duration of SARS-CoV-2 antibodies in a local COVID-19 outbreak and following vaccination","volume":"9","author":"Hedges JF","year":"2021","unstructured":"Hedges JF, Thompson MA, Snyder DT, Robison A, Taylor MP, Jutila MA. Titers, prevalence, and duration of SARS-CoV-2 antibodies in a local COVID-19 outbreak and following vaccination. Vaccines (Basel). 2021, 9:587. 10.3390\/vaccines9060587","journal-title":"Vaccines (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang W","year":"2020","unstructured":"Zhang W, Du RH, Li B, et al.. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020, 9:386-9. 10.1080\/22221751.2020.1729071","journal-title":"Emerg Microbes Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30589-2","article-title":"Risk of COVID-19 in health-care workers in Denmark: an observational cohort study","volume":"20","author":"Iversen K","year":"2020","unstructured":"Iversen K, Bundgaard H, Hasselbalch RB, et al.. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020, 20:1401-8. 10.1016\/S1473-3099(20)30589-2","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18848-0","article-title":"SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden","volume":"11","author":"Rudberg AS","year":"2020","unstructured":"Rudberg AS, Havervall S, M\u00e5nberg A, et al.. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020, 11:5064. 10.1038\/s41467-020-18848-0","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2023.06.011","article-title":"SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection","volume":"38","author":"Li Z","year":"2023","unstructured":"Li Z, Xiang T, Liang B, et al.. SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection. Virol Sin. 2023, 38:606-19. 10.1016\/j.virs.2023.06.011","journal-title":"Virol Sin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06156-x","article-title":"Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population","volume":"21","author":"Bichara CD","year":"2021","unstructured":"Bichara CD, da Silva Gra\u00e7a Amoras E, Vaz GL, et al.. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population. BMC Infect Dis. 2021, 21:443. 10.1186\/s12879-021-06156-x","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3689618","article-title":"Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India","volume":"68","author":"Goenka M","year":"2020","unstructured":"Goenka M, Afzalpurkar S, Goenka U, et al.. Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India. J Assoc Physicians India. 2020, 68:14-9. 10.2139\/ssrn.3689618","journal-title":"J Assoc Physicians India"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1182","article-title":"Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"9","author":"Jiang C","year":"2020","unstructured":"Jiang C, Wang Y, Hu M, et al.. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Transl Immunology. 2020, 9:e1182. 10.1002\/cti2.1182","journal-title":"Clin Transl Immunology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-9. 10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12270","article-title":"Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit","volume":"3","author":"Suleyman G","year":"2020","unstructured":"Suleyman G, Fadel RA, Malette KM, et al.. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020, 3:e2012270. 10.1001\/jamanetworkopen.2020.12270","journal-title":"JAMA Netw Open"},{"key":"ref20","unstructured":"Delta wave sweeps from west to east UK. (2021). Accessed. October 23, 2021: https:\/\/health-study.zoe.com\/press-release\/delta-wave-sweeps-from-west-to-east-uk."},{"key":"ref21","unstructured":"BSMMU. 98% of Bangladesh\u2019s Covid patients infected with Delta variant. (2021). Accessed: October 23, 2021: https:\/\/www.dhakatribune.com\/bangladesh\/2021\/08\/05\/bsmmu-98-of-bangladesh-s-covid-patients-are-infected-with-delta-va...."},{"key":"ref22","unstructured":"COVID-19 study. loss of smell not a common symptom of Delta variant. (2021). Accessed: October 23, 2021: https:\/\/odishabytes.com\/covid-19-study-loss-of-smell-not-a-common-symptom-of-delta-variant\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa618","article-title":"Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection","volume":"223","author":"Crawford KH","year":"2021","unstructured":"Crawford KH, Dingens AS, Eguia R, et al.. Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021, 223:197-205. 10.1093\/infdis\/jiaa618","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25989","article-title":"A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex","volume":"92","author":"Zeng F","year":"2020","unstructured":"Zeng F, Dai C, Cai P, et al.. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020, 92:2050-4. 10.1002\/jmv.25989","journal-title":"J Med Virol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22831","article-title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","volume":"28","author":"Simonnet A","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy J, et al.. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020, 28:1195-9. 10.1002\/oby.22831","journal-title":"Obesity (Silver Spring)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048970","article-title":"Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset","volume":"50","author":"Figueiredo-Campos P","year":"2020","unstructured":"Figueiredo-Campos P, Blankenhaus B, Mota C, et al.. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur J Immunol. 2020, 50:2025-40. 10.1002\/eji.202048970","journal-title":"Eur J Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab172","article-title":"Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study","volume":"73","author":"den Hartog G","year":"2021","unstructured":"den Hartog G, Vos ER, van den Hoogen LL, et al.. Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study. Clin Infect Dis. 2021, 73:2155-62. 10.1093\/cid\/ciab172","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215414","article-title":"SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study","volume":"75","author":"Shields A","year":"2020","unstructured":"Shields A, Faustini SE, Perez-Toledo M, et al.. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020, 75:1089-94. 10.1136\/thoraxjnl-2020-215414","journal-title":"Thorax"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.09.1484","article-title":"Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh","volume":"101","author":"Shirin T","year":"2020","unstructured":"Shirin T, Bhuiyan TR, Charles RC, et al.. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh. Int J Infect Dis. 2020, 101:220-5. 10.1016\/j.ijid.2020.09.1484","journal-title":"Int J Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233588","article-title":"Work-related COVID-19 transmission in six Asian countries\/areas: a follow-up study","volume":"15","author":"Lan FY","year":"2020","unstructured":"Lan FY, Wei CF, Hsu YT, Christiani DC, Kales SN. Work-related COVID-19 transmission in six Asian countries\/areas: a follow-up study. PLoS One. 2020, 15:e0233588. 10.1371\/journal.pone.0233588","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdaa170","article-title":"Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19","volume":"43","author":"Zaidi S","year":"2021","unstructured":"Zaidi S, Rizwan F, Riaz Q, et al.. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19. J Public Health (Oxf). 2021, 43:3-8. 10.1093\/pubmed\/fdaa170","journal-title":"J Public Health (Oxf)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14765","article-title":"Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area","volume":"324","author":"Moscola J","year":"2020","unstructured":"Moscola J, Sembajwe G, Jarrett M, Farber B, Chang T, McGinn T, Davidson KW. Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area. JAMA. 2020, 324:893-5. 10.1001\/jama.2020.14765","journal-title":"JAMA"},{"key":"ref33","unstructured":"17% Londoners, 5% of UK residents have COVID-19 antibodies. (2020). Accessed. September 27, 2021: https:\/\/www.livemint.com\/news\/world\/-17-londoners-5-of-uk-residents-have-covid-19-antibodies-11590148840735.html."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.02.104","article-title":"Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic","volume":"105","author":"Rodriguez A","year":"2021","unstructured":"Rodriguez A, Arrizabalaga-Asenjo M, Fernandez-Baca V, Lainez MP, Al Nakeeb Z, Garcia JD, Payeras A. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic. Int J Infect Dis. 2021, 105:482-6. 10.1016\/j.ijid.2021.02.104","journal-title":"Int J Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9666","article-title":"Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China","volume":"3","author":"Lai X","year":"2020","unstructured":"Lai X, Wang M, Qin C, et al.. Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Netw Open. 2020, 3:e209666. 10.1001\/jamanetworkopen.2020.9666","journal-title":"JAMA Netw Open"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1200","article-title":"Coronavirus disease 2019 (COVID-19) infections among healthcare workers, Los Angeles County, February-May 2020","volume":"73","author":"Hartmann S","year":"2021","unstructured":"Hartmann S, Rubin Z, Sato H, Yong OK, Terashita D, Balter S. Coronavirus disease 2019 (COVID-19) infections among healthcare workers, Los Angeles County, February-May 2020. Clin Infect Dis. 2021, 73:e1850-4. 10.1093\/cid\/ciaa1200","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.26.20079244","article-title":"Seroprevalence of COVID-19 virus infection in Guilan province, Iran. [Preprint]","author":"Shakiba M","year":"2020","unstructured":"Shakiba M, Nazari SSH, Mehrabian F, Rezvani SM, Ghasempour Z. Seroprevalence of COVID-19 virus infection in Guilan province, Iran. [Preprint]. Emerg Infect Dis. 2020, 10.1101\/2020.04.26.20079244","journal-title":"Emerg Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.31.20166249","article-title":"Reconciling epidemiological models with misclassified case-counts for SARS-CoV-2 with seroprevalence surveys: a case study in Delhi, India. [Preprint]","author":"Bhattacharyya R","year":"2020","unstructured":"Bhattacharyya R, Bhaduri R, Kundu R, Salvatore M, Mukherjee B. Reconciling epidemiological models with misclassified case-counts for SARS-CoV-2 with seroprevalence surveys: a case study in Delhi, India. [Preprint]. medRxiv. 2020, 10.1101\/2020.07.31.20166249","journal-title":"medRxiv"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxae030","article-title":"Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery","volume":"218","author":"Ali M","year":"2024","unstructured":"Ali M, Longet S, Neale I, et al.. Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery. Clin Exp Immunol. 2024, 218:78-92. 10.1093\/cei\/uxae030","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328909-dynamics-of-sars-cov-2-immunoglobulin-g-antibody-among-hospitalized-patients-and-healthcare-workers-during-the-delta-wave-in-bangladesh","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T15:07:13Z","timestamp":1744556833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328909-dynamics-of-sars-cov-2-immunoglobulin-g-antibody-among-hospitalized-patients-and-healthcare-workers-during-the-delta-wave-in-bangladesh"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.82175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,13]]}}}